ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW

Aspire-Lakewood Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$8.41−0.37 (-4.21%)

Close on Oct 19, 2026

Market cap: $8.73M
P/E (TTM): –
Dividend yield: –

Aspire-Lakewood Holdings, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Revenue	0.01	–	–	–
Cost of Revenue	0.01	–	–	–
Gross Profit	0.00	–	–	–
Research & Development	0.92	0.14	–	–
Selling, General & Admin	18	1.07	–	–
Selling & Marketing	0.79	0.13	–	–
General & Administrative	18	0.94	1.34	0.98
Operating Expenses	19	1.21	1.34	0.98
Operating Income	-19	-1.21	–	–
Interest Expense	8.53	0.10	0.01	–
Interest & Investment Income	–	0.55	5.81	4.32
Other Non-Operating Income	-5.13	-0.10	5.80	4.32
Pretax Income	-24	-1.31	–	–
Income Tax Expense	–	0.00	–	–
Net Income incl. Noncontrolling Interests	–	–	4.46	3.34
Net Income	-24	-1.31	4.46	3.34
EPS (Diluted)(per share)	-16.38	-1.90	–	–
Shares Outstanding (Basic, Weighted)(shares)	1.49	0.69	–	–
Shares Outstanding (Diluted, Weighted)(shares)	1.49	0.69	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: -25.0%
Operating margin: -7494.8%
Net margin: -11314.1%
Return on equity, FY2025: 618.5%

Financial strength

Current ratio: 7.99
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 721.6%

Valuation

P/E ratio: –
Price to sales: 89.38
Price to book: 0.74
Dividend yield: –